Pages that link to "Q67213435"
Jump to navigation
Jump to search
The following pages link to Comparison of subcutaneous apomorphine versus dispersible madopar latency and effect duration in Parkinson's disease patients: a double-blind single-dose study. (Q67213435):
Displaying 12 items.
- Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study (Q22242027) (← links)
- Levodopa-induced response fluctuations in patients with Parkinson's disease: strategies for management. (Q35129374) (← links)
- Subcutaneous apomorphine : an evidence-based review of its use in Parkinson's disease (Q35868420) (← links)
- Pharmacokinetic optimisation in the treatment of Parkinson's disease : an update. (Q36399714) (← links)
- Update on apomorphine for the rapid treatment of hypomobility ("off") episodes in Parkinson's disease. (Q36484966) (← links)
- Mucuna pruriens in Parkinson disease: A double-blind, randomized, controlled, crossover study (Q38374505) (← links)
- Novel Levodopa Formulations for Parkinson's Disease (Q38981419) (← links)
- Choice reaction time after levodopa challenge in parkinsonian patients (Q40736455) (← links)
- Quantification of the dopaminergic response in Parkinson's disease (Q44011637) (← links)
- Apomorphine in the treatment of Parkinson's Disease (Q45183861) (← links)
- From medications to surgery: advances in the treatment of motor complications in Parkinson's disease (Q90087446) (← links)
- Apomorphine for Parkinson's Disease: Efficacy and Safety of Current and New Formulations (Q93040659) (← links)